Product Information
BUPRENORPHINE 20 MCG/HR PATCH is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $57.9346 per EA under NDC 00093365940. Its NADAC has been published 330 times since Dec 12, 2018.
Strength
20 ug/h
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093365940
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA204937On Market Since
11/26/2018
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 20 MCG/HR PATCH has been published 330 times since Dec 12, 2018, and over the history we have for it it has declined 57.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $57.9346 per EA |
|---|---|
| All-time high | $137.4668 (Feb 10, 2021) |
| All-time low | $42.3325 (Jul 17, 2024) |
| 52-week high | $58.2405 |
| 52-week low | $52.6588 |
| Median price | $83.8120 |
| Average price | $88.5206 |
| Largest weekly change | +51.6% (Aug 21, 2024) |
| Weeks tracked | 330 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 20 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 20 MCG/HR PATCH, manufactured by Teva Pharmaceuticals USA Inc., is $57.9346 per EA (NDC 00093365940), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 20 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 20 MCG/HR PATCH has declined 57.3%. It has been tracked across 330 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 20 MCG/HR PATCH?
Since Dec 12, 2018, the NADAC for BUPRENORPHINE 20 MCG/HR PATCH has ranged from a low of $42.3325 (Jul 17, 2024) to a high of $137.4668 (Feb 10, 2021), with a median of $83.8120 per EA.
Are there cheaper alternatives to BUPRENORPHINE 20 MCG/HR PATCH?
3 NADAC-published products share the same active ingredient, strength, and dosage form as BUPRENORPHINE 20 MCG/HR PATCH, but none are currently priced below it.
Who manufactures BUPRENORPHINE 20 MCG/HR PATCH?
BUPRENORPHINE 20 MCG/HR PATCH (NDC 00093365940) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification